Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma

Overview of attention for article published in Cochrane database of systematic reviews, September 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 148 tweets from 133 users, with an upper bound of 632,144 followers.

RT @MyaCubitt: Nebulisers were not best practice for asthma in EDs therefore we didn’t use them pre-COVID https://t.co/XqRLICCQHy https:/…

Nebulisers were not best practice for asthma in EDs therefore we didn’t use them pre-COVID https://t.co/XqRLICCQHy https://t.co/jzNRa4kFVe

RT @PeterWark1710: This is true and nebulisers are often unnecessary when pMDI spacers are just as effective and safer for bronchodilator u…

This is true and nebulisers are often unnecessary when pMDI spacers are just as effective and safer for bronchodilator use https://t.co/EcxLv2uGhA

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 144 additional tweets.